Business Description
Annovis Bio Inc
NAICS : 325411
SIC : 2833
ISIN : US03615A1088
Share Class Description:
ANVS: Ordinary SharesDescription
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.49 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -79.1 | |||||
| 3-Year EPS without NRI Growth Rate | -78.4 | |||||
| 3-Year FCF Growth Rate | -91.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 31.02 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.52 | |||||
| 9-Day RSI | 24.97 | |||||
| 14-Day RSI | 27.96 | |||||
| 6-1 Month Momentum % | 11.95 | |||||
| 12-1 Month Momentum % | -54.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.66 | |||||
| Quick Ratio | 2.66 | |||||
| Cash Ratio | 2.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.1 | |||||
| Shareholder Yield % | -20.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -23636.26 | |||||
| ROA % | -429.55 | |||||
| ROIC % | -1660.16 | |||||
| ROC (Joel Greenblatt) % | -1660.16 | |||||
| ROCE % | -596.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.42 | |||||
| Price-to-Tangible-Book | 8.42 | |||||
| EV-to-EBIT | -1.57 | |||||
| EV-to-Forward-EBIT | -2.23 | |||||
| EV-to-EBITDA | -1.57 | |||||
| EV-to-Forward-EBITDA | -1.1 | |||||
| EV-to-FCF | -2.07 | |||||
| Price-to-Net-Current-Asset-Value | 9.46 | |||||
| Price-to-Net-Cash | 12.54 | |||||
| Earnings Yield (Greenblatt) % | -63.69 | |||||
| FCF Yield % | -37.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ANVS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Annovis Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.84 | ||
| Beta | 1.14 | ||
| Volatility % | 168.15 | ||
| 14-Day RSI | 27.96 | ||
| 14-Day ATR ($) | 0.491169 | ||
| 20-Day SMA ($) | 5.731 | ||
| 12-1 Month Momentum % | -54.04 | ||
| 52-Week Range ($) | 4.21 - 22.49 | ||
| Shares Outstanding (Mil) | 13.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Annovis Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Annovis Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Annovis Bio Inc Frequently Asked Questions
What is Annovis Bio Inc(ANVS)'s stock price today?
The current price of ANVS is $5.01. The 52 week high of ANVS is $22.49 and 52 week low is $4.21.
When is next earnings date of Annovis Bio Inc(ANVS)?
The next earnings date of Annovis Bio Inc(ANVS) is 2025-04-02 Est..
Does Annovis Bio Inc(ANVS) pay dividends? If so, how much?
Annovis Bio Inc(ANVS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers